首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >Correlation of CXCL12 Expression and FoxP3+ Cell Infiltration with Human Papillomavirus Infection and Clinicopathological Progression of Cervical Cancer
【2h】

Correlation of CXCL12 Expression and FoxP3+ Cell Infiltration with Human Papillomavirus Infection and Clinicopathological Progression of Cervical Cancer

机译:CXCL12表达和FoxP3 +细胞浸润与人乳头瘤病毒感染与宫颈癌临床病理进展的相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human cervical cancer is an immunogenic tumor with a defined pattern of histopathological and clinical progression. Tumor-infiltrating T cells contribute to immune control of this tumor; however, cervical cancer dysregulates this immune response both through its association with human papillomavirus (HPV) infection and by producing cytokines and chemokines. Animal tumor models have revealed associations between overproduction of the chemokine stromal cell-derived factor-1 (SDF-1 or CXCL12) and dysregulation of tumor-specific immunity. We therefore proposed that CXCL12 expression by cervical precancerous and cancerous lesions correlates with histopathological progression, loss of immune control of the tumor, and HPV infection. We found a significant association between cancer stage and CXCL12 expression for squamous and glandular lesions as well as with the HPV16+ (high-risk) status of the neoplastic lesions. Cancer progression was correlated with increasing levels of FoxP3 T-cell infiltration in the tumor. FoxP3 and CXCL12 expression significantly correlated for squamous and glandular neoplastic lesions. These observations were supported by enzyme-linked immunosorbent assay and Western blotting. In addition, we demonstrated CXCL12 expression by dyskaryotic cells in ThinPrep cervical smears. This study robustly links increased CXCL12 expression and FoxP3+-cell infiltration to HPV infection and progression of cervical cancer. It supports the detection of CXCL12 in cervical smears and biopsies as an additional biomarker for this disease.
机译:人宫颈癌是一种免疫原性肿瘤,具有明确的组织病理学和临床进展模式。肿瘤浸润性T细胞有助于对该肿瘤的免疫控制。然而,子宫颈癌通过与人乳头瘤病毒(HPV)感染的关联以及产生细胞因子和趋化因子来调节这种免疫反应。动物肿瘤模型显示趋化因子基质细胞衍生因子1(SDF-1或CXCL12)的过度生产与肿瘤特异性免疫功能异常之间存在关联。因此,我们提出宫颈癌前病变和癌性病变的CXCL12表达与组织病理学进展,肿瘤免疫控制丧失和HPV感染相关。我们发现鳞状和腺性病变的癌症分期与CXCL12表达之间以及癌性病变的HPV16 +(高危)状态之间存在显着相关性。癌症进展与肿瘤中FoxP3 T细胞浸润水平的升高有关。 FoxP3和CXCL12表达与鳞状和腺瘤性病变密切相关。这些观察得到酶联免疫吸附测定和蛋白质印迹的支持。此外,我们证明了ThinPrep宫颈涂片中的核动力细胞表达CXCL12。这项研究强有力地将增加的CXCL12表达和FoxP3 + 细胞浸润与HPV感染和宫颈癌的进展联系起来。它支持在宫颈涂片和活组织检查中检测CXCL12,作为该疾病的其他生物标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号